Gilead Sciences Inc. shares slipped 0.12% to $67.93 Wednesday. This proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.12% to 4,374.30 and the Dow Jones Industrial Average DJIA rising 0.13% to 34,933.23.
Gilead Sciences Inc. closed $11.01 below its 52-week high ($78.94), which the company reached on July 20th. The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ rose 0.68% to $170.42, Merck & Co. Inc. MRK rose 0.01% to $77.62, and AbbVie Inc. ABBV rose 0.64% to $117.36.
In terms of valuation, GILD is currently trading at a Forward P/E ratio of 9.6. This valuation marks a discount compared to its industry’s average Forward P/E of 23.23.Investors should also note that GILD has a PEG ratio of 0.63 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock’s expected earnings growth rate. The Medical – Biomedical and Genetics were holding an average PEG ratio of 1.39 at yesterday’s closing price.